Results

Total Results: over 10,000 records

Showing results for "indication".
Users also searched for: medication reconciliation

7881. HIT for Medication Safety in Critical Access Hospitals - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/publication/p20hs015325-hartzema-final-report-2005.pdf
      January 01, 2005 - HIT for Medication Safety in Critical Access Hospitals - Final Report …

7882. Use of Multiple Concurrent Antipsychotics in Children (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
      May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children 1 Use of Multiple Concurrent Antipsychotics in Children Section 1. Basic Measure Information 1.A. Measure Name Use of Multiple Concurrent Antipsychotics in Children 1.B. Measure Number 0126 1.C. Measure Description Please provide a non-technical descript…

7883. Final Progress Report: Drug-Drug Interaction Clinical Decision Support Conference Series (pdf file)
      www.ahrq.gov/sites/default/files/2024-01/malone-report.pdf
      January 01, 2024 - Final Progress Report: Drug-Drug Interaction Clinical Decision Support Conference Series Drug-Drug Interaction Clinical Decision Support Conference Series Investigators: Daniel C. Malone, RPh, PhD, Principal Investigator Mary L. Brown, PhD, Co-Investigator Lisa E. Hines, PharmD, Co-Investigator Amy Grizzle, Pha…

7884. Final Progress Report: Transforming the Medication Regimen Review Process of High-Risk Drugs Using a Patient-Centered, Telemedicine-Based Approach to Prevent ADEs in the Nursing Home (pdf file)
      www.ahrq.gov/sites/default/files/2024-02/kane-gill-report.pdf
      January 01, 2024 - Final Progress Report: Transforming the Medication Regimen Review Process of High-Risk Drugs Using a Patient-Centered, Telemedicine-Based Approach to Prevent ADEs in the Nursing Home Transforming the Medication Regimen Review Process of High-Risk Drugs Using a Patient- Centered, Telemedicine-Based Approach to Prevent…

7885. Timeliness of Confirmatory Testing for Sickle Cell Disease (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-132-fullreport.pdf
      January 23, 2017 - Timeliness of Confirmatory Testing for Sickle Cell Disease Timeliness of Confirmatory Testing for Sickle Cell Disease Section 1. Basic Measure Information 1.A. Measure Name Timeliness of Confirmatory Testing for Sickle Cell Disease 1.B. Measure Number 0132 1.C. Measure Description Please provide a non…

7886. 2023 National Healthcare Quality and Disparities Report (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es-rev.pdf
      January 01, 2023 - 2023 National Healthcare Quality and Disparities Report 2023 National Healthcare Quality and Disparities Report Executive Summary This document is in the public domain and may be used and reprinted without permission. Citation of the source is appreciated. Suggested citation: 2023 National Healthcare Qual…

7887. Hospital Stays in Medicare Advantage Plans Versus the Traditional Medicare Fee-for-Service Program, 2013 #198
      hcup-us.ahrq.gov/reports/statbriefs/sb198-Hospital-Stays-Medicare-Advantage-Versus-Traditional-Medicare.jsp
      December 01, 2015 - Hospital Stays in Medicare Advantage Plans Versus the Traditional Medicare Fee-for-Service Program, 2013 #198 An official website of the Department of Health & Human Services Search All AHRQ Website…

7888. Development of a Primary Care Guie for Implementing Evidence-Based Screening and Counseling for Unhealthy Alcohol Use With Epic-Based Electronic Health Record Tools: A Pilot Dissemination Project (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-unhealthy-alcohol-use-final.pdf
      September 01, 2018 - Development of a Primary Care Guie for Implementing Evidence-Based Screening and Counseling for Unhealthy Alcohol Use With Epic-Based Electronic Health Record Tools: A Pilot Dissemination Project Methods Research Report Development of a Primary Care Guide for Implementing Evidence-Based Screening and…

7889. AHRQ Slide Template 2019-Regular (pdf file)
      hcup-us.ahrq.gov/news/exhibit_booth/HCUPOverviewDeck_121422.pdf
      February 09, 2022 - AHRQ Slide Template 2019-Regular The Healthcare Cost and Utilization Project (HCUP) HCUP Database Overview Agency for Healthcare Research and Quality (AHRQ) What Is HCUP? Introduction to HCUP The HCUP Partnership State Federal Industry Sponsored by the Agency for Healthcare Research and Quality The…

7890. Trends in Hospital Readmissions for Four High-Volume Conditions, 2009-2013 #196
      hcup-us.ahrq.gov/reports/statbriefs/sb196-Readmissions-Trends-High-Volume-Conditions.jsp
      November 01, 2015 - Trends in Hospital Readmissions for Four High-Volume Conditions, 2009-2013 #196 An official website of the Department of Health & Human Services Search All AHRQ Websites Careers Contact …

7891. Evidence Summary: Breast Cancer: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/breast-cancer-screening
      April 30, 2024 - results not yet published NRSI used propensity score matching to adjust for potential confounding by indication

7892. Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
      February 01, 2012 - Disorder (Manic or Mixed) None named Pfizer NCT01269710 Second-Generation Antipsychotic Treatment Indication … for confounding, appropriate repeated measures may increase ability to control for confounding by indication

7893. A Patient Safety Program & Research Evaluation of U.S. Navy Pharmacy Refill Clinics (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Reige.pdf
      March 01, 2004 - Indication for medication 2. Strength and dosage of medication 3.

7894. Voluntary Hospital Coalitions to Promote Patient Safety (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Rask.pdf
      January 01, 2004 - system (133 hospitals or 88 percent of members) chose to report their data, which may serve as one indication

7895. 2019 CAHPS Health Plan Survey Database Chartbook (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2019_hpchartbook.pdf
      January 01, 2019 - The number of plans and respondents shown in each table provides some indication of the variation in

7896. Final Progress Report: Improving Transplant Med Safety through a Pharmacist-Led, mHealth-Based Program (pdf file)
      www.ahrq.gov/sites/default/files/2024-02/taber-report.pdf
      January 01, 2024 - Clinical medication errors included duplicate therapy, no indication, untreated condition, high/low

7897. 2020 CAHPS Health Plan Survey Database Chartbook (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2020_hp_chartbook.pdf
      January 01, 2020 - end of each section, there is table that provides the number of plans and respondents to provide an indication

7898. Disposition of Comments - Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2025-update-disposition-comments.pdf
      January 01, 2025 - This will give an indication about the trend in PTSD care and research.

7899. MS Protocol draft_12_12-13 clean[2] (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/multiple-sclerosis_research-protocol.pdf
      December 17, 2013 - Disease-modifying treatments Generic (Administration) Manufacturer (Trade Name) FDA-Approved Indication

7900. Evidence Summary: Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
      August 01, 2023 - NTDs by dosage, duration, and timing Dosage: 4 studies (1 cohort, 3 case-control); n = 26,791 No indication